Breast Cancer Research

official impact factor 5.79

This article is part of the supplement: VIII Madrid Breast Cancer Conference: Latest Advances in Breast Cancer

Developing a prediction model for benefit from fulvestrant in heavily pretreated metastatic breast cancer patients

E Amir, OC Freedman, S Chia, T Petrella, S Dent, K Tonkin, I Ahmad, D Rayson, G Dranitsaris and M Clemons

Breast Cancer Research 2009, 11(Suppl 1):P29 doi:10.1186/bcr2312

Accesses  

  • Last 30 days: 11 accesses
  • Last 365 days: 138 accesses
  • All time: 434 accesses